Resource Summary

Clinical Question:
In patients with coronary artery disease who have stent placement and/or acute coronary syndrome (ACS)^ should we prescribe dual antiplatelet therapy (DAPT)^ like clopidogrel plus aspirin^ beyond 12 months?

Bottom-line:
Current evidence and guidelines suggest that it is reasonable to continue dual antiplatelet therapy for 12 months following stent placement or acute coronary syndrome. After 12 months^ one antiplatelet (example clopidogrel) may be stopped and low-dose ASA continued.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2012-9-4
Last Updated on PCR: 2017-03-31 15:27:09